425 results on '"Mancardi, Giovanni"'
Search Results
2. Resting‐state functional connectivity and motor imagery brain activation
3. Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy
4. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study
5. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
6. Recapitulation of B Cell Differentiation in the Central Nervous System of Patients with Multiple Sclerosis
7. Chapter 11 - Hematopoietic stem cell transplantation for multiple sclerosis
8. Chapter 1 - Introduction to HSCT for neurologic diseases
9. Different MRI patterns in MS worsening after stopping fingolimod
10. How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
11. Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study
12. Delirium in the acute phase after stroke: comparison between methods of detection
13. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy
14. Evaluation of IAUGC indices and two DCE-MRI pharmacokinetic parameters assessed by two different theoretical algorithms in patients with brain tumors
15. Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
16. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
17. Cell-based therapeutic strategies for multiple sclerosis
18. Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis
19. Basal ganglia are active during motor performance recovery after a demanding motor task
20. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
21. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
22. Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
23. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
24. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
25. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study
26. The spectrum of GNE mutations: allelic heterogeneity for a common phenotype
27. SI_nonumbers – Supplemental material for Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates
28. Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method
29. Human mesenchymal stem cells modulate B-cell functions
30. Structural integrity of callosal midbody influences intermanual transfer in a motor reaction-time task
31. Autologous hematopoietic stem cell transplantation versus alemtuzumab in aggressive MS: a retrospective real-word study (4096)
32. Tailoring B-cells depleting therapy in MS according to memory B-cells monitoring: a pilot study (2159)
33. Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates
34. Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017
35. BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society
36. Frontal Networks Play a Role in Fatigue Perception in Multiple Sclerosis
37. Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
38. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
39. The Italian Natalizumab Registry: A 1-Year Follow-Up: 072.
40. RITUXIMAB EFFICACY IN CIDP ASSOCIATED WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
41. Carcinoma of the tongue mimicking bulbar amyotrophic lateral sclerosis
42. Relapses After Treatment With Rituximab in a Patient With Multiple Sclerosis and Anti–Myelin-Associated Glycoprotein Polyneuropathy
43. Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage
44. Predictors of response to rituximab in patients with neuropathy and anti–myelin associated glycoprotein immunoglobulin M
45. Symptomatic therapy in multiple sclerosis
46. Assessment of Normal-Appearing White and Gray Matter in Patients With Primary Progressive Multiple Sclerosis: A Diffusion-Tensor Magnetic Resonance Imaging Study
47. Cerebellar ataxia: Quantitative assessment and cybernetic interpretation
48. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study
49. Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis
50. Preserved Brain Functional Plasticity After Upper Limb Task-Oriented Rehabilitation in Progressive Multiple Sclerosis (S33.002)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.